Investigator Perspectives

Treatment Options for Stage III Unresectable NSCLC After Chemoradiotherapy

February 15th 2019

Lung Cancer

New Immunotherapeutic Agents Broaden Treatment Options for Chronic Lymphocytic Leukemia

January 9th 2019

Chronic Lymphocytic Leukemia

PI3K Inhibitors in R/R Follicular Lymphoma

January 7th 2019

Treatment Options for Recurrent Metastatic Triple-Negative Breast Cancer

December 27th 2018

Breast Cancer

SIRT for Nonresectable CRC With Liver Metastases

October 31st 2018

Colorectal Cancer

Systemic Treatment of Metastatic Cutaneous Squamous Cell Carcinoma

October 31st 2018

Skin Cancer

Evolving NSCLC Treatment Paradigm

August 23rd 2018

Lung Cancer

Upfront Therapy for mRCC

July 27th 2018

Kidney Cancer

NKTR-214 & Nivolumab: Synergistic Activity Across Tumor Types

July 11th 2018

General Cancer

Endocrine Therapy for HR+ Metastatic Breast Cancer

July 10th 2018

Breast Cancer

PARP Inhibitors in Ovarian Cancer

June 22nd 2018

Treatment of Newly Diagnosed Advanced Kidney Cancer

March 23rd 2018

Kidney Cancer

Changing Treatment Landscape in Nonmetastatic CRPC

March 20th 2018

Prostate Cancer

Immunotherapy in Unresectable Locally Advanced NSCLC

March 20th 2018

Lung Cancer

Immunotherapy Use in Newly Diagnosed NSCLC

March 8th 2018

Lung Cancer

IMiD Sequencing in Multiple Myeloma

January 10th 2018

Multiple Myeloma